Malignant Melanoma: Contemporary Management

EP. 1: Management of Stage III Melanoma

June 28th 2019

EP. 2: Molecular Testing for Stage III Melanoma

June 28th 2019

EP. 3: Stage III Melanoma: Adjuvant Therapy Trials

June 28th 2019

EP. 4: Stage III Melanoma: Personalized Management

June 28th 2019

EP. 5: Stage III Melanoma: Changes to Staging System

June 28th 2019

EP. 6: Stage III Melanoma: Neoadjuvant Therapy

June 28th 2019

EP. 7: Pooled Analysis of Neoadjuvant Therapy

June 28th 2019

EP. 8: Progression on Adjuvant Therapy

June 28th 2019

EP. 9: Frontline Therapy in Melanoma

June 28th 2019

EP. 10: Clinical Trials for Frontline Therapy in Melanoma

June 28th 2019

EP. 11: BRAF/MEK Inhibitors in Metastatic Melanoma

June 28th 2019

EP. 12: Metastatic Melanoma Brain Metastases

June 28th 2019

EP. 13: Intralesional Therapy for Metastatic Melanoma

June 28th 2019

EP. 14: Melanoma: Progression After Immunotherapy

June 28th 2019

EP. 15: Novel Agents for the Treatment of Melanoma

June 28th 2019

EP. 16: Future of Treating Melanoma

June 28th 2019

EP. 17: The Role of BRAF Mutations in Melanoma

June 28th 2019

EP. 18: Combination Therapy in Mutated Melanoma

June 28th 2019

EP. 19: Management of Patients with BRAF-Mutated Melanoma

June 28th 2019

EP. 20: The Use of Dual Targeted Therapy in Metastatic Melanoma

June 28th 2019

NEXT PAGE
PREVIOUS PAGE